Skip to main content
. 2017 Aug 7;36:105. doi: 10.1186/s13046-017-0573-6

Fig. 2.

Fig. 2

Survival analyses of cancer patients based on expression of MYBL2 and FoxM1. a Compare overall survival time between MYBL2 (left) or FoxM1 (right) higher expression levels and lower-expression-level in 79 glioma tissues. b Compare overall survival time between MYBL2 (left) or FoxM1 (right) higher expression levels and lower expression levels in LGG. c Associations between MYBL2 (left) and FoxM1 (right) gene expression levels and disease-free survival in LGG. d Compare overall survival time between MYBL2 (left) or FoxM1 (right) higher expression levels and lower-expression-level in HGG. e Associations between MYBL2 (left) and FoxM1 (right) gene expression levels and disease-free survival in HGG